Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda

J L Prodger, T Hirbod, G Kigozi, F Nalugoda, S J Reynolds, R Galiwango, K Shahabi, D Serwadda, M J Wawer, R H Gray, R Kaul, Rakai Genital Immunology Research Group, Nehemiah Kighoma, Denis Tumuramye, Emma Mbagiira, John-Bosco Kubaawo, Yahaya Isabirye, Patrick Mulema, James Teba, Boru Atukunda, Herbert Mayengo, Mary Nakafeero, Stephen Mugamba, Mary Nakyeyune, Margaret Anyokorit, Deo Male, Dan Kayiwa, Sarah Kalibbala, Lawrence Lubyayi, Ouma Joseph Otobi, Moses Kakanga, John Baptist Okech, Grace Okello, Gerald Aluma, Ivan Ssebugenyi, Ambrose Balikudembe, J L Prodger, T Hirbod, G Kigozi, F Nalugoda, S J Reynolds, R Galiwango, K Shahabi, D Serwadda, M J Wawer, R H Gray, R Kaul, Rakai Genital Immunology Research Group, Nehemiah Kighoma, Denis Tumuramye, Emma Mbagiira, John-Bosco Kubaawo, Yahaya Isabirye, Patrick Mulema, James Teba, Boru Atukunda, Herbert Mayengo, Mary Nakafeero, Stephen Mugamba, Mary Nakyeyune, Margaret Anyokorit, Deo Male, Dan Kayiwa, Sarah Kalibbala, Lawrence Lubyayi, Ouma Joseph Otobi, Moses Kakanga, John Baptist Okech, Grace Okello, Gerald Aluma, Ivan Ssebugenyi, Ambrose Balikudembe

Abstract

Human immunodeficiency virus (HIV) susceptibility is heterogenous, with some HIV-exposed but seronegative (HESN) individuals remaining uninfected despite repeated exposure. Previous studies in the cervix have shown that reduced HIV susceptibility may be mediated by immune alterations in the genital mucosa. However, immune correlates of HIV exposure without infection have not been investigated in the foreskin. We collected sub-preputial swabs and foreskin tissue from HESN (n=20) and unexposed control (n=57) men undergoing elective circumcision. Blinded investigators assayed swabs for HIV-neutralizing IgA, innate antimicrobial peptides, and cytokine levels. Functional T-cell subsets from foreskin tissue were assessed by flow cytometry. HESN foreskins had elevated α-defensins (3,027 vs. 1,795 pg ml(-1), P=0.011) and HIV-neutralizing IgA (50.0 vs. 13.5% of men, P=0.019). Foreskin tissue from HESN men contained a higher density of CD3 T cells (151.9 vs. 69.9 cells mm(-2), P=0.018), but a lower proportion of these was Th17 cells (6.12 vs. 8.04% of CD4 T cells, P=0.007), and fewer produced tumor necrosis factor α (TNFα) (34.3 vs. 41.8% of CD4 T cells, P=0.037; 36.9 vs. 45.7% of CD8 T cells, P=0.004). A decrease in the relative abundance of susceptible CD4 T cells and local TNFα production, in combination with HIV-neutralizing IgA and α-defensins, may represent a protective immune milieu at a site of HIV exposure.

Figures

Figure 1. Levels of soluble innate immune…
Figure 1. Levels of soluble innate immune proteins in foreskin secretions
HESN (hatched bars) and unexposed control men (open bars). Sub-preputial swabs collected before surgery were assayed for levels of soluble innate immune proteins by ELISA. Median concentration (with range) of innate peptide in 1mL collection volume is displayed (HESN n=18; Controls n=37).
Figure 2. The ability of IgA isolated…
Figure 2. The ability of IgA isolated from the foreskin to neutralize HIV
IgA was purified from foreskin secretions and incubated with a primary clade C viral isolate, which was subsequently challenged with PBMCs. The ability of IgA-treated virus to infect PBMCs was measured through p24 production. Capacity to neutralization HIV was defined as 67% less p24 production compared to reference sample. The proportion of men in each group with HIV-neutralizing IgA is shown (HESN n=18; Controls n=37).
Figure 3. T cell subsets in the…
Figure 3. T cell subsets in the blood and foreskin
HESN (hatched bars) and unexposed control men (open bars). The proportion of CD3+ T cells expressing either CD4 or CD8 was measured on PBMCs and foreskin cells using flow cytometry (B); representative flow cytometry plots showing the gating strategy for foreskin cells are shown in A. Proportions of T cells subsets were normalized to the number of CD3 T cells per mm2 of foreskin tissue (obtained using IHC) to obtain absolute numbers of each cell type (C) (HESN n=20, Controls n=57).
Figure 4. CD4 T cell subsets in…
Figure 4. CD4 T cell subsets in the blood and foreskin
HESN (hatched bars) and unexposed control men (open bars). CCR5 expression was measured on PBMCs and foreskin CD4 T cells using flow cytometry (representative foreskin plot in A). Th17 cells were identified by production of IL17a by CD4 T cells in response to stimulation with PMA and ionomycin (representative foreskin plot in D). Summary data of the proportion of CCR5+ CD4 T cells and Th17 cells in the blood and foreskin are shown in B and E. Absolute numbers of cells, obtained by IHC of CD3, are shown in C and F (HESN n=20, Controls n=57).
Figure 5. Inflammatory cytokine production by CD8…
Figure 5. Inflammatory cytokine production by CD8 (A–E) and CD4 (F–J) T cells
HESN (hatched bars) and unexposed control men (open bars). T cells isolated from foreskin tissue were challenged with PMA and ionomycin and subsequent TNFα and IFNγ production by either CD8+ T cells or CD8- T cells (a proxy for CD4 T cells) was measured by flow cytometry (representative plots shown for CD8 (A) and CD4 T cells (F). Summary data of the proportion of CD8 T cells producing TNFα or IFNγ shown in B and D, respectively. Absolute numbers of each cell type, obtained through CD3 IHC, are shown in C and E. Similarly, proportions of CD4 T cells producing TNFα or IFNγ shown in G and I, and absolute numbers of each cell type are shown in H and J (HESN n=20, Controls n=57).
Figure 6. HIV-specific CD8 T cells responses…
Figure 6. HIV-specific CD8 T cells responses in the foreskin
CD8 T cells isolated from foreskin tissue were challenged with a pool of cross-clade HIV peptides previously shown to be highly antigenic in an East African population. (A) TNFα and IFNγ production by CD8 T cells was measured by flow cytometry. (B) Frequency of response for HESN and unexposed control men. An HIV-specific response was defined as cytokine production 3 times greater than observed in unstimulated cells and a minimum of 0.3% (HESN n=20, Controls n=57).

References

    1. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8:447–457.
    1. Levinson P, et al. HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS ONE. 2012;7:e31996.
    1. Levinson P, et al. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS. 2009;23:309–317.
    1. Quinones-Mateu ME, et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids. 2003;17:F39–F48.
    1. Zapata W, et al. Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res. 2008;6:531–538.
    1. Lajoie J, et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol. 2012;5:277–287.
    1. Burgener A, et al. Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men. Aids. 2012;26:1857–1867.
    1. Iqbal SM, et al. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. Aids. 2009;23:1669–1677.
    1. Hirbod T, et al. Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr. 2006;43:137–143.
    1. Hirbod T, et al. HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals. Curr HIV Res. 2008;6:28–33.
    1. Iqbal SM, et al. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis. 2005;192:728–738.
    1. Hasselrot K, et al. Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. Aids. 2009;23:329–333.
    1. Choi RY, et al. Cervicovaginal HIV-1 Neutralizing IgA Detected among HIV-1-Exposed Seronegative Female Partners in HIV-1-Discordant Kenyan Couples. Aids. 2012
    1. Hirbod T, et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. Aids. 2008;22:727–735.
    1. Kaul R, et al. Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility. Aids. 2008;22:2049–2051.
    1. Zhou Z, et al. HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog. 2011;7:e1002100.
    1. Card Catherine M, et al. Decreased Immune Activation in Resistance to HIV −1 Infection Is Associated with an Elevated Frequency of CD4+CD25+FOXP3+Regulatory T Cells. The Journal of Infectious Diseases. 2009;199:1318–1322.
    1. Legrand FA, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE. 2006;1:e102.
    1. Bégaud E, et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology. 2006;3:35.
    1. Koning FA, et al. Low-Level CD4+ T Cell Activation Is Associated with Low Susceptibility to HIV-1 Infection. Journal of Immunology. 2005;175:6117–6122.
    1. Camara M, et al. Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. J Infect Dis. 2010;201:835–842.
    1. Chege D, et al. Blunted IL17/IL22 and Pro-Inflammatory Cytokine Responses in the Genital Tract and Blood of HIV-Exposed, Seronegative Female Sex Workers in Kenya. PLoS ONE. 2012;7:e43670.
    1. McLaren PJ, et al. HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis. 2010;202(Suppl 3):S339–S344.
    1. Auvert B, et al. Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial. PLoS Medicine. 2005;2
    1. Bailey R, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet. 2007;369:643–656.
    1. Gray RH, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet. 2007;369:657–666.
    1. Prodger JL, et al. Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol. 2012;5:121–128.
    1. Gray RH, et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS. 2000;14:2371–2381.
    1. Johnson KE, et al. Effects of HIV-1 and Herpes Simplex Virus Type 2 Infection on Lymphocyte and Dendritic Cell Density in Adult Foreskins from Rakai, Uganda. Journal of Infectious Diseases. 2011;203:602–609.
    1. Prodger JL, et al. Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin. Aids. 2012;26:1319–1322.
    1. Beyrer C, et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis. 1999;179:59–67.
    1. Broliden K, et al. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol Lett. 2001;79:29–36.
    1. Devito C, et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. Aids. 2000;14:1917–1920.
    1. Kaul R, et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. Aids. 1999;13:23–29.
    1. Lo Caputo S, et al. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. Aids. 2003;17:531–539.
    1. Hirbod T, Broliden K, Kaul R. Genital immunoglobulin A and HIV-1 protection: virus neutralization versus specificity. Aids. 2008;22:2401–2402.
    1. Fiore JR, et al. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. New Microbiol. 2000;23:85–92.
    1. Horton RE, et al. Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV. AIDS Res Hum Retroviruses. 2009;25:83–92.
    1. Soderlund J, et al. Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells. AIDS Res Hum Retroviruses. 2007;23:101–106.
    1. Cicala C, et al. The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proceedings of the National Academy of Sciences. 2009;106:20877–20882.
    1. Li Q, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009;458:1034–1038.
    1. Gosselin A, et al. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J Immunol. 2010;184:1604–1616.
    1. Monteiro P, et al. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immunol. 2011;186:4618–4630.
    1. Zhang ZQ. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proceedings of the National Academy of Sciences. 2004;101:5640–5645.
    1. Jaspan HB, et al. Immune Activation in the Female Genital Tract During HIV Infection Predicts Mucosal CD4 Depletion and HIV Shedding. J Infect Dis. 2011
    1. Fahrbach KM, Barry SM, Anderson MR, Hope TJ. Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission. Mucosal Immunology. 2010;3:410–418.
    1. Ganor Y, et al. Within 1-h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans–T cell conjugates. Mucosal Immunology. 2010;3:506–522.
    1. Kim CJ, et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 2012
    1. Gamiel JL, et al. Improved Performance of Enzyme-Linked Immunosorbent Assays and the Effect of Human Immunodeficiency Virus Coinfection on the Serologic Detection of Herpes Simplex Virus Type 2 in Rakai, Uganda. Clinical and Vaccine Immunology. 2008;15:888–890.
    1. Kaul R, et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett. 2001;79:3–13.

Source: PubMed

3
Iratkozz fel